Health

Add as a preferred source on Google

WHO Finds AMR Plans Lag as Study Projects 39.1 Million Deaths

WHO's 2026 survey found 173 of 183 countries had national plans, but just 22% reported both necessary funding and full implementation.

Updated 2 min read
A laboratory worker prepares bacterial culture plates at a public health laboratory in Geneva, Switzerland. / TokenPost.ai (mono)
A laboratory worker prepares bacterial culture plates at a public health laboratory in Geneva, Switzerland. / TokenPost.ai (mono)

A study in The Lancet projects 39.1 million deaths from antimicrobial resistance between 2025 and 2050, while World Health Organization (WHO) findings show few countries report both necessary funding and full implementation of national plans.

The figure comes from the study's reference scenario, which put the range at 33.0 million to 46.0 million deaths. WHO cited the rounded 39 million estimate in its 2025 call to action and said AMR could add up to $412 billion in annual economic costs, with low-resource settings disproportionately affected.

WHO released findings Nov. 16 from its 2026 Tracking AMR Country Self-assessment Survey, completed by 183 countries. A total of 173 countries reported national plans, compared with 79 in 2017. Yet only 22% reported both necessary funding and full implementation.

WHO estimated that antibiotic resistance was detected in roughly one of every six bacterial infections confirmed through laboratory testing worldwide in 2023. The agency said resistance can make routine infections harder to treat and increase risks associated with surgery, childbirth and cancer care.

The survey also highlighted weaknesses in diagnostic capacity. Thirty-six percent of countries reported a national reference laboratory able to test for the bacteria and fungi selected by WHO. The agency's 2030 target calls for 80% of countries to have comprehensive capacity for bacterial and fungal resistance testing. WHO released a catalogue of diagnostic tests and a toolkit of laboratory procedures to help countries expand testing.

WHO Director-General Tedros Adhanom Ghebreyesus said, “An unfulfilled plan helps no one,” as he urged governments to invest in infection prevention, surveillance, essential antimicrobials and diagnostics.

European Union surveillance by the European Centre for Disease Prevention and Control (ECDC) has also shown uneven trends in resistant bloodstream infections.

World AMR Awareness Week runs Nov. 18-24 under the theme “One Health, one action: Prevent AMR now.”

Related articles

View all